The pharmaceutical Pfizer The COVID-19 pandemic is expected to last up to 2024, although in some countries it could become a endemic disease. This has been assured by the company’s chief scientist, Mikael Dolsten, in an intervention before the company’s investors.
The presentation, which took place last Friday, contemplates that in some regions the levels of COVID-19 infections will continue in the coming years, becoming endemic but with low contagions in the same period.
By 2024, according to these forecasts, the disease should be considered endemic throughout the planet. “When and how the end of the pandemic happens will depend on the evolution of the disease, the effectiveness in the inoculation of vaccines and treatments and the distribution of sera to countries where vaccination rates are low, “said Dolsten. The company acknowledges that the new variants they can change that scenario.
On vaccine for children 2 to 4 years, Pfizer acknowledges that the study is not achieving its intended results, so injections for this age group will be delayed. In this trial they were given two doses with three micrograms of their vaccine, although they found that it does not elicit the same immune response as a higher dose vaccine in older children. In babies from six to 24 months it does seem to work, according to the pharmacist.
Ricardo is a renowned author and journalist, known for his exceptional writing on top-news stories. He currently works as a writer at the 247 News Agency, where he is known for his ability to deliver breaking news and insightful analysis on the most pressing issues of the day.
